Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CMV chemotherapy for pure squamous cell cancer of the urinary tract
ISRCTN84356042Phase 2Completed
- Sponsor
- Medical Research Council
- Start
- Oct 1993
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of cisplatin, methotrexate and vinblastine in bladder squamous cell carcinoma, sponsored by Medical Research Council. Primary endpoint: Overall response at 9 weeks. Started Oct 1993; status: completed.
02
Drugs
cisplatinmethotrexatevinblastine
03
Conditions
bladder squamous cell carcinoma
Beyond the preview
Go deeper on ISRCTN84356042.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN84356042.